Stein Robert Benjamin 4
4 · MIMEDX GROUP, INC. · Filed Jun 30, 2022
Insider Transaction Report
Form 4
Stein Robert Benjamin
EVP, Research and Development
Transactions
- Sale
Common Stock
2022-06-28$3.47/sh−14,600$50,662→ 334,005 total
Footnotes (1)
- [F1]The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.47 to $3.48, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.